“I couldn't connect the wires in my brain.” Young adult cancer survivors' experience with cognitive functioning
…, T Welniak, L Gudenkauf, ML Maconi… - Psycho …, 2024 - Wiley Online Library
Objective There is a dearth of literature describing young adult (YA) cancer survivors' experiences
with cancer‐related cognitive impairment (CRCI). We aimed to elucidate CRCI among …
with cancer‐related cognitive impairment (CRCI). We aimed to elucidate CRCI among …
A Consolidated Framework for Implementation Research-based process to develop theoretically-informed human papillomavirus vaccination educational materials for …
Objective To develop theory-informed human papillomavirus (HPV) vaccine education
materials that appeal to 18–26-year-olds. Methods First, draft materials informed by Theory of …
materials that appeal to 18–26-year-olds. Methods First, draft materials informed by Theory of …
Qualitative evaluation of the implementation and future sustainability of an e-referral system for smoking cessation at a US NCI-designated comprehensive cancer …
Background Promoting smoking cessation is recognized as an essential part of cancer care.
Moffitt Cancer Center, supported by the National Cancer Institute Cancer Moonshot Cancer …
Moffitt Cancer Center, supported by the National Cancer Institute Cancer Moonshot Cancer …
It's not all about coursework: Narratives of inclusion and exclusion among university students receiving disability accommodations
ML Maconi, SE Green, SC Bingham - Promoting Social Inclusion, 2019 - emerald.com
… Melinda Maconi conducted seven of the interviews as part of her MA thesis project.
Students enrolled in an undergraduate research experience course taught by Sara Green and …
Students enrolled in an undergraduate research experience course taught by Sara Green and …
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
LM Gudenkauf, MN Chavez, ML Maconi… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The field of radionuclide therapy (RNT) for prostate cancer (PC) is growing rapidly, with
recent Food and Drug Administration approval of the first 177 Lu-PSMA ligand. We aimed to …
recent Food and Drug Administration approval of the first 177 Lu-PSMA ligand. We aimed to …
“I've Used My Wide Array of Skills to Create a Life for Myself”: Managing Narratives with Competing Goals in an Arts-based Disability Ally Organization
ML Maconi - Disability Alliances and Allies: Opportunities and …, 2020 - emerald.com
Purpose: Artists with disabilities use their bodies and minds to create art. Yet, the prevailing
cultural narrative that art is “therapeutic” for people with disabilities shifts attention from their …
cultural narrative that art is “therapeutic” for people with disabilities shifts attention from their …
[BOOK][B] " I'm Not Broken": Perspectives of Students with Disabilities on Identity-making and Social Inclusion on a College Campus
ML Maconi - 2016 - search.proquest.com
Narratives help individuals to make sense of their lives and their everyday worlds. Within these
narratives, individuals make sense of identities. Historically, people with disabilities have …
narratives, individuals make sense of identities. Historically, people with disabilities have …
A Tale of Two Art Programs: Art & Identity for People with Disabilities
ML Maconi - 2022 - search.proquest.com
This dissertation explores the relationship between disability and art in individual and
organizational narratives told in the context of art programs that are designed to provide …
organizational narratives told in the context of art programs that are designed to provide …
More than therapy: Conformity and resistance in an organizational narrative of disability and the performing arts
ML Maconi - New Narratives of Disability, 2019 - emerald.com
Purpose Despite the legacies of many talented artists with disabilities, art programs for people
with disabilities are consistently framed as important because of their “therapeutic” value. …
with disabilities are consistently framed as important because of their “therapeutic” value. …
Developing a novel patient-reported outcome measure for patients with prostate cancer receiving radionuclide therapy: The FACT-RNT.
130 Background: The field of targeted radionuclide therapy (RNT) for prostate cancer (PC) is
growing rapidly with recent FDA approval of the first lutetium-177-PSMA-ligand. Commonly …
growing rapidly with recent FDA approval of the first lutetium-177-PSMA-ligand. Commonly …